Literature DB >> 14680831

Crystal structure of human PNP complexed with guanine.

Walter Filgueira de Azevedo1, Fernanda Canduri, Denis Marangoni dos Santos, José Henrique Pereira, Márcio Vinicius Bertacine Dias, Rafael Guimarães Silva, Maria Anita Mendes, Luiz Augusto Basso, Mário Sérgio Palma, Diógenes Santiago Santos.   

Abstract

Purine nucleoside phosphorylase (PNP) catalyzes the phosphorolysis of the N-ribosidic bonds of purine nucleosides and deoxynucleosides. PNP is a target for inhibitor development aiming at T-cell immune response modulation and has been submitted to extensive structure-based drug design. More recently, the 3-D structure of human PNP has been refined to 2.3A resolution, which allowed a redefinition of the residues involved in the substrate-binding sites and provided a more reliable model for structure-based design of inhibitors. This work reports crystallographic study of the complex of Human PNP:guanine (HsPNP:Gua) solved at 2.7A resolution using synchrotron radiation. Analysis of the structural differences among the HsPNP:Gua complex, PNP apoenzyme, and HsPNP:immucillin-H provides explanation for inhibitor binding, refines the purine-binding site, and can be used for future inhibitor design.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680831     DOI: 10.1016/j.bbrc.2003.10.190

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Molecular dynamics studies of a hexameric purine nucleoside phosphorylase.

Authors:  Fernando Berton Zanchi; Rafael Andrade Caceres; Rodrigo Guerino Stabeli; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-08-11       Impact factor: 1.810

2.  Molecular modeling and dynamics studies of purine nucleoside phosphorylase from Bacteroides fragilis.

Authors:  Ivani Pauli; Luis Fernando Saraiva Macedo Timmers; Rafael Andrade Caceres; Luiz Augusto Basso; Diógenes Santiago Santos; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-01-27       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.